Kevin M. Yurkerwich, PhD


Kevin Yurkerwich is an experienced complex civil litigator focused on patent matters in the federal courts, and a special emphasis on cases involving the life sciences.

Mr. Yurkerwich has appeared in more than 65 cases in federal district courts and has significant experience with all stages of civil litigation, including managing discovery and resolving discovery disputes, preparing expert reports, taking and defending fact and expert depositions, preparing fact and expert witnesses for trial, and drafting and negotiating settlement agreements. In his cases, Mr. Yurkerwich has led the development of technical strategy, including by engaging and working directly with leading academic and industry experts in chemistry, biology, pharmacy, pharmacology, pharmaceutical formulation, immunology, oncology, and molecular genetics and diagnostics, among other disciplines.

Mr. Yurkerwich has made numerous court appearances at trials, pre-trial conferences, claim construction hearings, and discovery conferences in district court proceedings, at oral hearings before the Patent Trial and Appeal Board, and at oral argument in Federal Circuit appeals. Since 2019, Mr. Yurkerwich has personally taken 26 depositions and defended 11 depositions. And over the course of his career, Mr. Yurkerwich has been involved in more than 75 depositions. Over the last five years, four of Mr. Yurkerwich’s patent cases have proceeded to trial providing him with a broad range of trial experience. Mr. Yurkerwich also has significant writing experience. In the district court, he has drafted court filings, including pre- and post-trial briefs, claim construction briefs, and briefing on motions to compel. Mr. Yurkerwich also has extensive experience with all aspects of written discovery, including the preparation of detailed and extensive infringement and invalidity contentions and motion practice related to parties seeking leave to amend infringement and invalidity contentions.

Mr. Yurkerwich has appeared in eight IPR proceedings before the PTAB. In those cases, he has drafted briefs on behalf of Patent Owners and Petitioners. Mr. Yurkerwich has also made multiple appearances before the Federal Circuit and drafted successful appellate briefs.

Mr. Yurkerwich has significant experience working on important pro bono efforts related to immigration, housing rights, and the representation of indigent clients. Mr. Yurkerwich has worked extensively with Project Citizenship to help eligible legal permanent residents overcome barriers to becoming US citizens.

Prior to joining the firm, Mr. Yurkerwich clerked for the Honorable Paul S. Grewal of the US District Court for the Northern District of California. During law school, Mr. Yurkerwich was a summer associate in the IP Litigation Practice in WilmerHale's Palo Alto office and in the Silicon Valley office of another major law firm. He was also a summer law clerk at the Habeas Corpus Resource Center in San Francisco, a state organization that provides legal representation for indigent petitioners in death penalty habeas corpus proceedings before the Supreme Court of California and the federal courts.

Before becoming a lawyer, Mr. Yurkerwich earned his doctorate in chemistry at Columbia University. At Columbia, Mr. Yurkerwich worked with Professor Ged Parkin where he developed synthetic pathways to subvalent gallium and indium compounds and conducted extensive research related to mercury remediation. As an undergraduate at the Massachusetts Institute of Technology, Mr. Yurkerwich worked with Professor Kit Cummins and explored molybdenum-based alkyne metathesis precursors.


Representative Cases

  • Representation of pharmaceutical company in a multi-defendant, multi-patent ANDA litigation in District of New Jersey
  • Representation of pharmaceutical company in a multi-defendant, multi-patent ANDA litigation in the District of Delaware
  • Representation of pharmaceutical company in a multi-patent litigation in the District of New Jersey
  • Representation of medical device company in defending a patent infringement case involving surgical ablation devices
  • Representation of pharmaceutical company in an inter partes review proceeding before the Patent Trial and Appeal Board
  • Representation of molecular diagnostics company in inter partes review proceedings before the Patent Trial and Appeal Board


Insights & News


  • Education

    • JD, Stanford Law School, 2013

      Stanford Journal of Law, Science & Policy
    • PhD, Chemistry, Columbia University, 2010

    • MPhil, Chemistry, Columbia University, 2009

    • MA, Chemistry, Columbia University, 2007

    • SB, Chemistry, Massachusetts Institute of Technology, 2005

  • Admissions

    • California

    • Massachusetts

    • US Patent and Trademark Office

  • Clerkships

    • The Hon. Paul S. Grewal, US District Court for the Northern District of California, 2013 - 2014



Unless you are an existing client, before communicating with WilmerHale by e-mail (or otherwise), please read the Disclaimer referenced by this link.(The Disclaimer is also accessible from the opening of this website). As noted therein, until you have received from us a written statement that we represent you in a particular manner (an "engagement letter") you should not send to us any confidential information about any such matter. After we have undertaken representation of you concerning a matter, you will be our client, and we may thereafter exchange confidential information freely.

Thank you for your interest in WilmerHale.